Netherlands-based Royal Philips has launched a new integrated interventional X-ray solution called NeuroSuite to support and improve minimally invasive image-guided neurological interventions.
The new NeuroSuite system extends treatment options by providing more effective device guidance and placement in every neuroradiology procedure.
Go deeper with GlobalData
According to the company, new interventional neurology devices such as stents and flow diverters provide new treatments for ischemic stroke or large-neck aneurysm, but their increasingly smaller designs make devices more difficult to see with X-ray imaging.
The Philips NeuroSuite addresses these challenges with a biplane interventional x-ray system that combines two new detectors.
Royal Philips’s frontal FD20 detector delivers live 2D and 3D imaging to provide live navigation and immediate therapy feedback.
See Also:
The smaller, lateral FD15 detector can be positioned beyond the shoulders and very close to the head, the company said.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe shorter distance and combination of detectors offer sharp, full-brain imaging at a lower X-ray dose and 3D imaging optimised for neurovascular and spine interventions.
Philips Healthcare Interventional X-ray general manager Ronald Tabaksblat said: "Developed in collaboration with clinical partners around the world, Philips NeuroSuite has been designed for that purpose and underpins Philips’ global leadership position in live-image guidance technologies."
The new system includes Philips’ AlluraClarity, which reduces radiation dose by as much as 73% without compromising image quality, and VasoCT, which visualises intracranial devices in vessel context and vessel morphology down to perforator vessels.
The company said that the first NeuroSuite system was recently installed at Karolinska University Hospital, Stockholm, Sweden, and the system is currently not available in the US.
University of Paris faculty of medicine professor Jacques Moret said: "The next step in our collaboration with Philips is the NeuroSuite bringing enhanced vessel and device visualization and full head coverage.
"The new detector combination could be especially useful for stroke treatment."
Image: NeuroSuite is designed to support and enhance minimally invasive image-guided neurological interventions. Photo: courtesy of Koninklijke Philips NV.
